A Review of the Efficacy of FDA-Approved <i>B. anthracis</i> Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical Models

Anti-toxin agents for severe <i>B. anthracis</i> infection will only be effective if they add to the benefit of the two mainstays of septic shock management, antibiotic therapy and titrated hemodynamic support. Both of these standard therapies could negate benefits related to anti-toxin...

Full description

Bibliographic Details

Published in:	Toxins
Main Authors:	Zoe Couse, Xizhong Cui, Yan Li, Mahtab Moayeri, Stephen Leppla, Peter Q. Eichacker
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Subjects:	<i>B. anthracis</i> anthrax lethal and edema toxin shock antibiotic support hemodynamic support
Online Access:	https://www.mdpi.com/2072-6651/13/1/53